Executive vice president, Chief academic officer, Fred Hutchinson Cancer Center; Raisbeck Endowed Chair in Collaborative Research, Professor, University of Washington
Edward Chu was an expert in pharmacology whose research improved therapies for colorectal cancer, leading to the identification of new treatment targets and driving scientific advances in the field.